Inner Logic, a developer of an AI-powered software platform to simulate how implants, instruments, and surgical robots will perform inside the human body before committing to real-world testing, raised a $11.5 million seed round co-led by General Catalyst and Bison Ventures with participation from J2VP, Defined, PTX, Valia Ventures, Page One, Alumni Ventures, and Flare.
Inner Logic gives device manufacturers the infrastructure to design, test, and validate procedural devices across thousands of virtual patients and procedures before clinical deployment. The same infrastructure provides the capabilities needed to make surgical autonomy a reality.
Medical device manufacturers use Inner Logic to simulate how devices perform across thousands of virtual patients, grounded in real procedural data, before committing to physical testing. As devices become intelligent and autonomous, the same infrastructure provides the capabilities needed to make surgical autonomy a reality.
“Surgery is on the same path as autonomous driving, which became real once the industry built the simulation and data systems to show a car could drive itself. At Inner Logic, we are building that layer for all of procedural medicine, starting with the way devices are designed and tested. When device makers can develop and prove intelligent systems this way, the quality of a patient’s care stops depending on which hospital they can access or which surgeon is on call,” said Tito Porras, MD, MBA, Co-Founder and CEO, Inner Logic.